Published online before print December 18, 2008

This Article Full Text Full Text (PDF) All Versions of this Article: ajpath.2009.080350v1 174/1/164    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Omari, K. M. Articles by Raine, C. S. Search for Related Content PubMed PubMed Citation Articles by Omari, K. M. Articles by Raine, C. S. Related Collections Related Article

(American Journal of Pathology. 2009;174:164-176.)
© 2009 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2009.080350

Neuroprotection and Remyelination after Autoimmune Demyelination in Mice that Inducibly Overexpress CXCL1

Kakuri M. Omari^*, Sarah E. Lutz^*, Laura Santambrogio^*, Sergio A. Lira and Cedric S. Raine^*

From the Departments of Pathology (Neuropathology),^* Neurology, and Neuroscience, Albert Einstein College of Medicine, Bronx; and the Departments of Medicine, Immunology Institute, Mount Sinai School of Medicine, New York, New York

In rodents, the chemokine CXCL1 both induces the proliferation and inhibits the migration of oligodendrocyte precursor cells. We previously reported that in multiple sclerosis, the same chemokine is expressed by hypertrophic astrocytes, which associate with oligodendrocytes that express the receptor CXCR2. To investigate whether chemokines influence repair after autoimmune demyelination, we generated GFAP-rtTA x β-Gal-TRE-CXCL1 double-transgenic (Tg) mice that inducibly overexpress CXCL1 under the control of the astrocyte-specific gene, glial fibrillary acidic protein. Experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis, was induced in these animals (and controls) by the subcutaneous injection of myelin oligodendrocyte glycoprotein, and after disease onset, CXCL1 production was initiated by the intraperitoneal injection of doxycycline. Double-Tg animals displayed a milder course of disease compared with both single (CXCL1 or glial fibrillary acidic protein)-Tg and wild-type controls. Pathologies were similar in all groups during the acute stage of disease. During the chronic disease phase, both inflammation and demyelination were diminished in double-Tg mice and Wallerian degeneration was markedly decreased. Remyelination was strikingly more prominent in double-Tg mice, together with an apparent increased number of oligodendrocytes. Moreover, cell proliferation, indicated by BrdU incorporation within the central nervous system, was more widespread in the white matter of double-Tg animals. These findings suggest a neuroprotective role for CXCL1 during the course of autoimmune demyelination.